I believe the main thing to look out for after FDA is the rate of acceptance and implementation in the US market. So assuming FDA is approved by June, then the JUL-SEP and OCT-DEC quarterlies that follow should give a good picture of that.
All in all, assuming FDA is given by June 2025, then we should be able to see how PCK will travel by end of the year. By then, most, if not all of the other markets like infant, hospitals, home care, etc would have started. We will get to see some revenues from all these sources. I still expect to see PCK profitable by end of 2025. At worst, it should achieve profitability by no later than mid 2026. All these do predicate upon a successful FDA approval.
We are at the pointy end now. Success or not, all should be revealed by next year.
Add to My Watchlist
What is My Watchlist?
